È possibile la salute in carcere? Il disturbo da uso di sostanze e la comorbilità psichiatrica, la compless

Journal title MISSION
Author/s Giovanni Luca Galimberti
Publishing Year 2023 Issue 2022/59
Language Italian Pages 6 P. 47-52 File size 0 KB
DOI 10.3280/mis59-2022oa15380
DOI is like a bar code for intellectual property: to have more infomation click here

View article Download Open Access article

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

The definition “Dual Diagnosis” leads to the dangerous pitfall of understanding two distinct pathological elements and suggests to addiction and psychiatry specialists a non-interconnected approach.Therefore, we prefer to use the term comorbidity DUS and psychiatric disorder.This condition is increasingly common in clinical settings, especially within the prison setting.In this environment, clinical pictures are more complex because of the difficulties inherent in the inmate’s life, the complications related to the proper use of psychotropic drugs, and the different instances that gravitate around the diagnostic and certification processes.A diagnostic pathway that determines the temporality of the two disorders, clarifying the mutual influences, is essential; the use of objective diagnostic tools such as toxicological examinations and psychic tests is useful.Treatment must involve bringing to bear the knowledge and opportunities available to the field of Addiction and Psychiatry, with the cultural and operational rigidities of the two fields being overcome.In the treatment processes on comorbid inmates, a continuous relationship with external specialist services is necessary to create the conditions for the continuum of care.

Keywords: ; Comorbidity; Prison; Certification; Diagnosis; Psychiatric drugs

  1. (1) United Nations Office for Drug Control and Crime Prevention (UNODCCP), 2000.
  2. (2) DSM-5 (2014). Manuale diagnostico e statistico dei disturbo mentali quinta edizione.
  3. (3) EMCDDA (2004). Annual report on the state of the drugs problem in the European Union and Norway.
  4. (4) Benasayag M. (2007). L’epoca delle passioni tristi. Feltrinelli.
  5. (5) Cibn M. et al. (2014). L’alcol come elemento comune del poliabuso. Medicina delle dipendenze MDD.
  6. (6) Volkov N. (2008). National Institute on drug abuse NIDA “Is there relationship between childhood ADHD and later drug abuse?”.
  7. (7) Regier et al. (1999). JAMA, 264: 2511-8.
  8. (8) Clerici M., Carta et al. (1989). Substance abuse and psychopathology. Psychiat Epemiol 24.
  9. (9) Pani et al. (1991). Psychopathological heterogeneity in opium drug addicts. Minerva Psichiatr., lug.
  10. (10) Tempesta et al. (1995). Mental disorders of drug addicts in treatment: a study of prevalence with retrospective evaluation by means of structured diagnostic interviews, Minerva set Psich.
  11. (11) Fazel, Clerici et al. (2016). Lancet Psychiatry, 3: 871-881.
  12. (12) XV rapporto sulle condizioni di detenzione, a cura di Associazione Antigone, 2019.
  13. (13) Elbogan et al. (2009). The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry, Feb, 66(2): 152-61.
  14. (14) Cavalera C. et al. (2020). Substance use disorder and violent behavior in patients with severe mental disorders. Australian and New Zeland Journal of psychiatry.
  15. (15) Carpiniello, Vita, Mencacci (2019). Violence and mental disorders. Springer, e-book, Nov.
  16. (16) Maremmani I. (2014). Substance abuse and psychosis. The strange case of opioids. Eur. Rev. Med. Pharmacology Sci.
  17. (17) Ortiz-Medina M. et al. (2018). Cannabis consumption and psychosis or schizophrenia develop. Int. J. Soc. Psychiatric, novembre.
  18. (18) Marconi A. (2016). Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophrenia Bull., Sept.
  19. (19) Relazione annuale al Parlamento sul fenomeno delle tossicodipendenze in Italia, anno 2021.
  20. (20) OMS (2009). World report on violence and health.
  21. (21) Minkoff K. (1989). An integrated treatment model for dual diagnosis of psychosis and addiction. Hospital and Community Psychiatry, 40: 1031-1036.
  22. (22) Mueser K.T., Drake R.E., Noordsy D.L. (1998a). Integrated mental health and substance abuse treatment for severe psychiatric disorders. Journal of Practical Psychiatry and Behavioral Health, 4: 129-139.
  23. (23) Tirado Munoz J. et al. (2018). Dual diagnosis in Depression: treatment recommendations. Addictiones. Jan.
  24. (24) Giampieri M. et al. (2013). Doppia Diagnosi e consumo di risorse. Journal of Psychopathology, 19: 199-207.
  25. (25) Ismail M. et al. (2016). Journal of the college of Physicians Pakistan, vol. 26: 130-133.
  26. (26) Serio G. (2019). Specificità della doppia diagnosi: il tempo della cura e la difficoltà del trattamento. VIII Cong. Naz. FeDerSerD, ott.
  27. (27) Lugoboni et al. (2013). Benzodiazepine, uso abuso e dipendenza, CLAD onlus.

Giovanni Luca Galimberti, È possibile la salute in carcere? Il disturbo da uso di sostanze e la comorbilità psichiatrica, la compless in "MISSION" 59/2022, pp 47-52, DOI: 10.3280/mis59-2022oa15380